Barry Alexander is a healthcare regulatory and transactional attorney who advises providers, private equity sponsors and institutional investors in transactions where reimbursement mechanics, payor policy and operational structure affect valuation, diligence and post-closing risk. He has more than 35 years of experience advising clients in reimbursement-driven sectors where revenue integrity, compliance and valuation are closely connected.

Barry focuses on specialized healthcare industries, including specialty pharmacy, infusion and compounding, behavioral health with a concentration in ABA, oncology, clinical laboratories, genetic and urine drug testing, durable medical equipment, diagnostic imaging and ophthalmology.

Barry is engaged in transactions where reimbursement considerations are central to valuation, diligence and execution. He advises clients on how services are delivered, coded and reimbursed and how those mechanics are evaluated under audit, payor review and investor diligence.

His experience includes:

• Structuring transactions where reimbursement models influence valuation and deal terms.
• Leading regulatory diligence focused on revenue quality and payment defensibility.
• Advising on Medicare, Medicaid and commercial payor reimbursement across fee-for-service and managed care environments.
• Resolving coverage, coding and payment issues with CMS, Medicare contractors and commercial payors.
• Managing government investigations and audits involving reimbursement-related claims.
• Navigating multi-state regulatory frameworks, including licensure and corporate practice of medicine requirements.
• Counseling on fraud and abuse laws, including the Anti-Kickback Statute and Stark Law.

Barry regularly works with private equity sponsors and platform companies on acquisitions, roll-ups and exit readiness. His guidance informs valuation, escrow and indemnity structures, diligence scope and post-closing integration.

He previously served as a board member of the American Health Law Association.